Science Explorer Interactive view Map
Company · Bothell · United States

OncoGenex Pharmaceuticals (United States)

oncogenex.comROR OpenAlex
World rank, all time
#11,613
of 42,892
Rank in United States
#2,556
of 8,685
Research works
142
▼ 72% vs 2013–17
Citations
11k
77.0 per fractional work
Top-10% rate
9.5%
record average 16.5%
Open access
33%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.67× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.30× its world share, 2 worksBiochemistry, Geneti…Neuroscience: 0.97× its world share, 0 worksNeuroscienceEngineering: 1.47× its world share, 1 worksEngineeringDentistry: 3.26× its world share, 0 worksDentistryMedicine: 0.94× its world share, 1 worksMedicineBusiness, Management and Accounting: 4.90× its world share, 1 worksBusiness, Management…Economics, Econometrics and Finance: 1.48× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.50× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.3×. Every wedge is a field page.

Who are the top researchers at OncoGenex Pharmaceuticals (United States)?

Ranked on the composite score, M. Shoyab, Gregory D. Plowman and A F Purchio lead among researchers whose main affiliation is OncoGenex Pharmaceuticals (United States).

  1. 1 M. Shoyab United States · #39,740 worldwide 488 citations · 36 works
  2. 2 Gregory D. Plowman United States · #63,042 worldwide 433 citations · 28 works
  3. 3 A F Purchio United States · #380,378 worldwide 157 citations · 15 works
All ranked researchers at OncoGenex Pharmaceuticals (United States)

Which keywords describe research at OncoGenex Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Cancer, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Angiogenesis and Immune Response.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation23▲ 74×3 topics
  2. Cancer21▲ 11×19 topics
  3. Monoclonal Antibodies12▲ 61×2 topics
  4. Therapeutic Antibodies12▲ 68×2 topics
  5. Antibody Engineering12▲ 83×1 topic
  6. Fc Receptors12▲ 83×1 topic
  7. Angiogenesis11▲ 18×11 topics
  8. Immune Response10▲ 11×7 topics
  9. Inflammation8▲ 2.6×17 topics
  10. Cancer Therapy8▲ 8.8×9 topics
  11. Monoclonal Antibody8▲ 77×2 topics
  12. Innate Immunity7▲ 14×8 topics
  13. Autoimmunity7▲ 23×4 topics
  14. Gene Therapy7▲ 18×4 topics
  15. Biopharmaceutical Production7▲ 60×2 topics
  16. Cancer Immunotherapy6▲ 33×3 topics
  17. Cell Culture6▲ 41×2 topics
  18. Glycans6▲ 56×1 topic
  19. Immune System6▲ 14×1 topic
  20. Genomic Integration6▲ 39×2 topics
  21. Immunotherapy6▲ 6.0×9 topics
  22. Antigen Presentation5▲ 38×2 topics
  23. Cancer Progression5▲ 17×4 topics
  24. Foxp35▲ 51×1 topic
  25. TGF-ß5▲ 22×1 topic
  26. Tumor Microenvironment5▲ 11×5 topics
  27. Mammalian Cells5▲ 92×1 topic
  28. Recombinant Protein5▲ 92×1 topic
  29. Immunity5▲ 10×4 topics
  30. Transcriptional Regulation5▲ 14×5 topics
  31. Dendritic Cells4▲ 27×1 topic
  32. Extracellular Matrix4▲ 13×4 topics
  33. Tumor Antigen4▲ 38×1 topic
  34. Vaccine4▲ 7.8×5 topics
  35. AAV4▲ 46×1 topic
  36. Viral Vectors4▲ 46×1 topic
  37. Breast Cancer4▲ 9.8×4 topics
  38. Metastasis4▲ 8.1×5 topics
  39. Tumor Suppression4▲ 24×3 topics
  40. PET Imaging4▲ 11×4 topics

Which research topics does OncoGenex Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: 3D Printing in Biomedical Research, Global Trade and Competitiveness, Smoking Behavior and Cessation and Metabolism, Diabetes, and Cancer.

3D Printing in Biomedica…13D Printing in Biomedical Research: 1 fractional worksGlobal Trade and Competi…0Global Trade and Competitiveness: 0 fractional worksSmoking Behavior and Ces…0Smoking Behavior and Cessation: 0 fractional worksMetabolism, Diabetes, and Cancer: 0 fractional worksCancer-related Molecular Pathways: 0 fractional worksCancer, Hypoxia, and Met…0Cancer, Hypoxia, and Metabolism: 0 fractional worksAdvanced Fluorescence Microscopy Techniques: 0 fractional worksAdvanced Biosensing Techniques and Applications: 0 fractional worksInsurance and Financial Risk Management: 0 fractional worksAgriculture Market Analysis Ukraine: 0 fractional works
Biomedical EngineeringStrategy and ManagementPhysiologyMolecular Biology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 3D Printing in Biomedical Research Biomedical Engineering 1 works
  2. 2 Global Trade and Competitiveness Strategy and Management 0 works
  3. 3 Smoking Behavior and Cessation Physiology 0 works
  4. 4 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
  5. 5 Cancer-related Molecular Pathways Oncology 0 works
  6. 6 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  7. 7 Advanced Fluorescence Microscopy Techniques Biophysics 0 works
  8. 8 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
  9. 9 Insurance and Financial Risk Management Economics and Econometrics 0 works
  10. 10 Agriculture Market Analysis Ukraine General Agricultural and Biological Sciences 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.0%not open67.0%

World: 28% of research is openly available.

with international co-authors12.5%domestic only87.5%

World: 19% is written across borders.

How has OncoGenex Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 72% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Bothell

All research institutions in Bothell

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.